在肺炎球菌蛋白疫苗的最新进展
Sha Li1, Hangeri Liang1, Shui-Hao Zhao2
1Zhuhai Key Laboratory of Basic and Applied Research in Chinese Medicine, School of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.
Frontiers in immunology
|October 11, 2023
概括
基于蛋白质的疫苗为对抗肺炎球菌感染提供了一个有希望的替代方案. 本综述探讨了这些新型蛋白质疫苗对抗Streptococcus pneumoniae的进展,挑战和未来方向.
科学领域:
- 微生物学 微生物学
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
背景情况:
- 肺炎球菌感染仍然是全球主要的健康威胁.
- 目前的多糖和合疫苗有局限性,包括血清型替代.
- 以蛋白质为基础的疫苗向保存的Streptococcus pneumoniae表面蛋白质是一个有希望的替代方案.
研究的目的:
- 审查开发基于蛋白质的肺炎球菌疫苗的进展情况.
- 讨论关键的蛋白质疫苗候选人和它们的有效性.
- 探索这个领域的挑战和未来的研究方向.
主要方法:
- 对肺炎球菌蛋白疫苗开发进展的文献综述.
- 对动物研究中疫苗接种结果的分析.
- 讨论挑战和未来的前景.
主要成果:
- 几种蛋白质疫苗候选人在临床前研究中显示出前景.
- 蛋白质疫苗向保存的抗原,可能提供更广泛的保护.
- 挑战包括优化免疫性和制造.
结论:
- 基于蛋白质的肺炎球菌疫苗代表了疫苗学的重大进展.
- 需要进一步的研究来克服开发障碍,并将这些疫苗推向临床使用.
- 这些疫苗有可能改善肺炎球菌疾病的全球控制.
相关概念视频
01:30Pneumonia V: Nursing management and Prevention
2.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
01:30Pneumonia I: Introduction
250
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
250
01:28Pneumonia IV: Management
350
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
350
01:51Vaccinations
44.6K
Overview
44.6K
01:29Pneumonia II: Pathophysiology
298
The pathophysiology of pneumonia involves the following steps:
298
01:26Bacterial Protein Maturation
22
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
22